Lysine deacetylation in ischaemic preconditioning: the role of SIRT1.
OBJECTIVE
Acute ischaemic preconditioning (IPC) induces protection against cardiac ischaemia-reperfusion (IR) via post-translational modification of key proteins. Lysine (Lys) acetylation is an important regulator of protein function, but this type of modification has not been studied in the context of IPC. We investigated Lys acetylation in IPC and its upstream regulation by SIRT1.


RESULTS
Hearts from C57BL/6 mice were Langendorff-perfused and subjected to IPC and IR injury. Mice were exposed to IPC by in vivo coronary artery occlusion. An isolated cardiomyocyte model of IPC was also developed. Lys acetylation was measured by western blotting, and pharmacological modulators of Lys acetylation were tested. More Lys deacetylation was observed in IPC, in the Langendorff, in vivo, and cellular IPC models; this was concurrent with an increase in SIRT1 activity measured by p53 Lys₃₇₉ deacetylation. IPC was not accompanied by changes in SIRT1 protein level, but evidence was obtained for SIRT1 modification by Small Ubiquitin-like Modifier (SUMOylation) in IPC. Furthermore, the specific SIRT1 inhibitor splitomicin reversed both IPC-mediated Lys deacetylation and IPC-induced cardioprotection. Inhibition of nicotinamide phosphoribosyltransferase (Nampt, an important enzyme which regulates SIRT1 activity by maintaining availability of the substrate NAD(+)) also blocked both IPC-induced deacetylation and cardioprotection.


CONCLUSIONS
Lys deacetylation occurs during IPC and an elevation in SIRT1 activity plays a role in this phenomenon. Inhibition of SIRT1, either directly or by restricting the availability of its substrate NAD(+), inhibits IPC. Together these data suggest a role for SIRT1-mediated Lys deacetylation in the mechanism of acute IPC.
Nadtochiy
Sergiy M
SM
Department of Anesthesiology, University of Rochester Medical Center, 601 Elmwood Avenue, Box 604, Rochester, NY 14642, USA. sergiy_nadtochiy@urmc.rochester.edu
Redman
Emily
E
Rahman
Irfan
I
Brookes
Paul S
PS
D000107:Acetylation; D000818:Animals; D004195:Disease Models, Animal; D019157:Ischemic Preconditioning, Myocardial; D008239:Lysine / Q000378:metabolism*; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D015428:Myocardial Reperfusion Injury / Q000378:metabolism*; D009206:Myocardium / Q000378:metabolism*; D032383:Myocytes, Cardiac / Q000166:cytology / Q000378:metabolism; D009243:NAD / Q000378:metabolism; D056564:Sirtuin 1 / Q000378:metabolism*
D009243:NAD; C470545:Sirt1 protein, mouse; D056564:Sirtuin 1; D008239:Lysine
Circ Res. 2005 Aug 19;97(4):329-36
16037573
Physiol Rev. 2008 Apr;88(2):581-609
18391174
Science. 2009 May 22;324(5930):1076-80
19461003
J Mol Cell Cardiol. 2009 Jun;46(6):960-8
19339206
Circ Res. 2009 Apr 10;104(7):879-86
19265035
Chem Biol Drug Des. 2009 Dec;74(6):619-24
19843076
Int J Biochem Cell Biol. 2009 Jan;41(1):185-98
18804549
Nature. 2007 Nov 29;450(7170):712-6
18046409
Am J Physiol. 1999 Sep;277(3):H874-84
10484406
J Biol Chem. 2010 Mar 12;285(11):8375-82
20089851
J Biol Chem. 2004 Jul 9;279(28):28873-9
15126506
Circulation. 1986 Nov;74(5):1124-36
3769170
Recent Pat Cardiovasc Drug Discov. 2007 Jun;2(2):133-8
18221111
Science. 2004 Mar 26;303(5666):2011-5
14976264
EMBO J. 2004 Jun 16;23(12):2369-80
15152190
Cardiovasc Res. 2007 Dec 1;76(3):473-81
17884027
Biochem J. 2003 Mar 15;370(Pt 3):737-49
12429021
J Biol Chem. 2004 Dec 3;279(49):50754-63
15381699
Free Radic Biol Med. 2009 Jun 15;46(12):1589-97
19303434
Biochim Biophys Acta. 2006 Feb;1762(2):223-31
16278076
J Neurochem. 2009 Apr;109(1):257-67
19200349
J Biol Chem. 2007 Nov 23;282(47):34356-64
17901049
J Biol Chem. 2010 Mar 12;285(11):8340-51
20061378
Nature. 2009 Jul 30;460(7255):587-91
19641587
Nature. 2009 Apr 23;458(7241):1056-60
19262508
Cell. 2001 Oct 19;107(2):149-59
11672523
Antioxid Redox Signal. 2006 Nov-Dec;8(11-12):2101-9
17034353
Proc Natl Acad Sci U S A. 2008 Mar 4;105(9):3374-9
18296641
Antioxid Redox Signal. 2010 Oct 1;13(7):1023-32
20392170
Am J Physiol Lung Cell Mol Physiol. 2007 Feb;292(2):L567-76
17041012
Biochem J. 2006 May 1;395(3):611-8
16436046
Science. 2008 Sep 12;321(5895):1493-5
18787169
Am J Physiol Heart Circ Physiol. 2003 Sep;285(3):H1220-8
12763745
Cancer Res. 2003 Nov 1;63(21):7436-42
14612543
Cardiovasc Res. 2002 Apr;54(1):140-51
12062370
Pharmacol Res. 2010 Jul;62(1):35-41
20026274
Nat Cell Biol. 2007 Nov;9(11):1253-62
17934453
J Mol Cell Cardiol. 2009 Jun;46(6):804-10
19285082
Circ Res. 2007 Nov 26;101(11):1155-63
17916778
J Biol Chem. 2003 Dec 26;278(52):52773-82
14534292
Cardiovasc Res. 2004 Feb 15;61(3):610-9
14962491
PLoS One. 2008;3(12):e4020
19107194
Nat Protoc. 2006;1(4):1872-8
17487171
Mol Med. 2001 Jun;7(6):406-17
11474134
J Mol Cell Cardiol. 2000 Jun;32(6):961-71
10888250
Biochemistry. 2004 Aug 3;43(30):9877-87
15274642
J Mol Cell Cardiol. 2007 Apr;42(4):812-25
17350035
Mol Cell Biol. 2006 Jan;26(1):28-38
16354677
Proc Natl Acad Sci U S A. 2008 Sep 23;105(38):14447-52
18794531
Circ Res. 2009 Oct 23;105(9):830-41
19850949
FASEB J. 2010 Sep;24(9):3145-59
20385619
J Mol Cell Cardiol. 2009 Jun;46(6):858-66
19118560
Proc Natl Acad Sci U S A. 2001 Dec 18;98(26):15113-8
11752457
Circ Res. 2009 Aug 28;105(5):481-91
19661458
J Mol Cell Cardiol. 2004 Dec;37(6):1195-203
15572049
Science. 2009 Jun 5;324(5932):1289-93
19498162
Circ Res. 2007 May 25;100(10):1512-21
17446436
Proc Natl Acad Sci U S A. 2007 Sep 11;104(37):14855-60
17785417
EMBO J. 2005 Mar 9;24(5):1021-32
15692560
Proc Natl Acad Sci U S A. 2009 Jun 30;106(26):10764-9
19528654
Mol Cell Biol. 2009 Aug;29(15):4116-29
19470756
J Biol Chem. 2005 Dec 30;280(52):43121-30
16207712
Am J Respir Crit Care Med. 2008 Apr 15;177(8):861-70
18174544
Can J Physiol Pharmacol. 2009 Apr;87(4):275-86
19370081
Am J Physiol Heart Circ Physiol. 2005 Feb;288(2):H971-6
15358610
EMBO J. 2002 May 15;21(10):2383-96
12006491